Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Noll

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Final report of the phase I trial of continuous infusion etanidazole (SR 2508): a Radiation Therapy Oncology Group studyC N Coleman, L Noll, N Riese, et al.
Cells|September 22, 2019
Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin ModelsJean Christopher Chamcheu, Stephane Esnault, Vaqar M Adhami, et al.
BMJ Open|June 11, 2026
The LIFE study: a cross-sectional study protocol for LIfestyle risk Factors for chronic disease across the stagEs of reproductive ageingLaura E Pernoud, Jamie L Noll, Paul A Gardiner, et al.
Mbio|October 17, 2019
Antibiotics and Host-Tailored Probiotics Similarly Modulate Effects on the Developing Avian Microbiome, Mycobiome, and Host Gene ExpressionTonya L Ward, Bonnie P Weber, Kristelle M Mendoza, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Final report of the phase I trial of continuous infusion etanidazole (SR 2508): a Radiation Therapy Oncology Group studyC N Coleman, L Noll, N Riese, et al.
Cells|September 22, 2019
Fisetin, a 3,7,3',4'-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin ModelsJean Christopher Chamcheu, Stephane Esnault, Vaqar M Adhami, et al.
BMJ Open|June 11, 2026
The LIFE study: a cross-sectional study protocol for LIfestyle risk Factors for chronic disease across the stagEs of reproductive ageingLaura E Pernoud, Jamie L Noll, Paul A Gardiner, et al.
Mbio|October 17, 2019
Antibiotics and Host-Tailored Probiotics Similarly Modulate Effects on the Developing Avian Microbiome, Mycobiome, and Host Gene ExpressionTonya L Ward, Bonnie P Weber, Kristelle M Mendoza, et al.
Pageof 9